Peptid-M/met-enkephalin induces modulation of the cell cycle. Its cytostatic effects with the prevention of mutations, and reduction of apoptosis (programmed cell death) suggest possible applications of this pentapeptide in different diseases which involve lymphocyte dysfunctions, chromosomal aberrations and/or abnormal PBL proliferation.